![John Cullity](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Cullity
Vorsitzender bei
HaemaLogiX Pty Ltd.
Vermögen: 4 Mio $ am 30.06.2026
Profil
John Cullity is currently the Chairman at HaemaLogiX Pty Ltd. He is also a Director at Theraly Fibrosis, Inc. and a Managing Director at Biosynergy Partners LLC.
Additionally, he is a Member at The Royal College of Physicians.
In his former positions, Dr. Cullity served as a Director of Health Economics at Merk Sharp & Dohme (Holdings) Pty Ltd. and Sanofi-Aventis Healthcare Pty Ltd. He was also a Non-Executive Director at Race Oncology Ltd. from 2018 to 2023 and a Director at Ceramedix Holdings LLC from 2015 to 2020.
Furthermore, he held the position of Senior Member-Business Development at Sanofi-Synthelabo, Inc. and worked as a Principal at Torreya Partners LLC from 2010 to 2017.
Dr. Cullity obtained a graduate degree from the London School of Economics & Political Science.
He also holds an undergraduate degree from The University of Western Australia and an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RACURA ONCOLOGY LTD 1.37% | 08.08.2025 | 2’694’642 ( 1.37% ) | 4 Mio $ | 30.06.2026 |
Aktive Positionen von John Cullity
| Unternehmen | Position | Beginn |
|---|---|---|
Biosynergy Partners LLC | Corporate Officer/Principal | 01.09.2013 |
Theraly Fibrosis, Inc.
 Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Direktor/Vorstandsmitglied | 01.09.2016 |
HaemaLogiX Pty Ltd.
 HaemaLogiX Pty Ltd. BiotechnologyHealth Technology Develops immunotherapies for blood cancers and B cell disorders | Vorsitzender | - |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von John Cullity
| Unternehmen | Position | Ende |
|---|---|---|
| RACURA ONCOLOGY LTD | Vorsitzender | 20.04.2023 |
Ceramedix Holdings LLC
 Ceramedix Holdings LLC Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutics company that develops antibody-based drugs | Direktor/Vorstandsmitglied | 01.03.2020 |
Torreya Partners LLC
 Torreya Partners LLC Investment ManagersFinance Provides financial advisory services | Corporate Officer/Principal | 01.01.2017 |
Sanofi-Aventis Healthcare Pty Ltd. | Corporate Officer/Principal | - |
Merk Sharp & Dohme (Holdings) Pty Ltd.
 Merk Sharp & Dohme (Holdings) Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals products | Corporate Officer/Principal | - |
Ausbildung von John Cullity
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Western Australia
 The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Synthelabo, Inc. | Health Technology |
Merk Sharp & Dohme (Holdings) Pty Ltd.
Merk Sharp & Dohme (Holdings) Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals products | Health Technology |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Provides financial advisory services | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Healthcare Pty Ltd. | |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
HaemaLogiX Pty Ltd.
HaemaLogiX Pty Ltd. BiotechnologyHealth Technology Develops immunotherapies for blood cancers and B cell disorders | Health Technology |
Biosynergy Partners LLC | |
Ceramedix Holdings LLC
Ceramedix Holdings LLC Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutics company that develops antibody-based drugs | Health Technology |
